Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · Real-Time Price · USD
2.870
+0.030 (1.06%)
Feb 21, 2025, 4:00 PM EST - Market closed
Synaptogenix Market Cap
Synaptogenix has a market cap or net worth of $3.89 million as of February 21, 2025. Its market cap has decreased by -6.93% in one year.
Market Cap
3.89M
Enterprise Value
-18.18M
1-Year Change
-6.93%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since December 15, 2020, Synaptogenix's market cap has decreased from $5.28M to $3.89M, a decrease of -26.34%. That is a compound annual growth rate of -7.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 3.89M | -17.29% |
| Dec 31, 2024 | 4.70M | -15.16% |
| Dec 29, 2023 | 5.54M | -34.23% |
| Dec 30, 2022 | 8.43M | -85.16% |
| Dec 31, 2021 | 56.80M | 652.77% |
| Dec 31, 2020 | 7.55M | 42.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |